178 related articles for article (PubMed ID: 23788956)
1. Treatment for papillary thyroid microcarcinoma.
Shi L; Chen JH; Wang ST; Xiong YQ; Huang T
Contemp Oncol (Pozn); 2013; 17(1):20-3. PubMed ID: 23788956
[TBL] [Abstract][Full Text] [Related]
2. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
3. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonic features of papillary thyroid microcarcinoma and non-microcarcinoma.
Zhang XL; Qian LX
Exp Ther Med; 2014 Oct; 8(4):1335-1339. PubMed ID: 25187850
[TBL] [Abstract][Full Text] [Related]
5. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
6. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
7. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
[TBL] [Abstract][Full Text] [Related]
8. Outcome of papillary thyroid microcarcinoma: Study of 1,990 cases.
Lu ZZ; Zhang Y; Wei SF; Li DS; Zhu QH; Sun SJ; Li M; Li LI
Mol Clin Oncol; 2015 May; 3(3):672-676. PubMed ID: 26137285
[TBL] [Abstract][Full Text] [Related]
9. Predictive features of central lymph node metastasis in papillary thyroid microcarcinoma: Roles of active surveillance in over-treatment.
Han B; Hao S; Wu J; Fang J; Han Z
Front Med (Lausanne); 2022; 9():906648. PubMed ID: 36226144
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
[TBL] [Abstract][Full Text] [Related]
11. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D
Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonographical, clinical and histopathological features of 1264 nodules with papillary thyroid carcinoma and microcarcinoma based on tumor size.
Seyrek NC; Baser H; Topaloglu O; Ozdemir D; Kilicarslan A; Ersoy R; Cakir B
Arch Endocrinol Metab; 2021 May; 64(5):533-541. PubMed ID: 34033293
[TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients.
Vasileiadis I; Karakostas E; Charitoudis G; Stavrianaki A; Kapetanakis S; Kouraklis G; Karatzas T
Eur J Clin Invest; 2012 Jun; 42(6):657-64. PubMed ID: 22168782
[TBL] [Abstract][Full Text] [Related]
14. Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated?
Dobrinja C; Pastoricchio M; Troian M; Da Canal F; Bernardi S; Fabris B; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S34-S39. PubMed ID: 28506411
[TBL] [Abstract][Full Text] [Related]
15. Papillary thyroid microcarcinoma: a surgical perspective.
Sakorafas GH; Giotakis J; Stafyla V
Cancer Treat Rev; 2005 Oct; 31(6):423-38. PubMed ID: 16005155
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
17. Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy.
Karatzas T; Vasileiadis I; Charitoudis G; Karakostas E; Tseleni-Balafouta S; Kouraklis G
Hormones (Athens); 2013; 12(4):529-36. PubMed ID: 24457401
[TBL] [Abstract][Full Text] [Related]
18. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience.
Pelizzo MR; Boschin IM; Toniato A; Pagetta C; Piotto A; Bernante P; Casara D; Pennelli G; Rubello D
Nucl Med Commun; 2004 Jun; 25(6):547-52. PubMed ID: 15167512
[TBL] [Abstract][Full Text] [Related]
19. RISK FACTORS FOR CENTRAL LYMPH NODE METASTASES IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA.
Wu X; Li B; Zheng C; He X
Endocr Pract; 2018 Dec; 24(12):1057-1062. PubMed ID: 30289307
[TBL] [Abstract][Full Text] [Related]
20. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases.
Medas F; Canu GL; Cappellacci F; Boi F; Lai ML; Erdas E; Calò PG
Front Endocrinol (Lausanne); 2020; 11():551. PubMed ID: 32982963
[No Abstract] [Full Text] [Related]
[Next] [New Search]
